Dr. John Ennen

FDA rules Avandia is only to be used with patients who have type 2 diabetes when no other medications work to control blood sugar. For years, the adverse affects of Avandia have far outwieghed the benefits of its use for patients. In 2007, research showed that patients taking Avandia were 43% more likely to experience a heart attack than those taking other diabetes drugs or no diabetes medication. The European Medicines Agency recommends Avandia be taken off the market but because of pharmaceuticals politics the FDA is only restricting its use. Avandia has been shown to increase the likelihood of:
cardiac failure, myocardial ischemia, congestive heart failure and myocardial ischemia during co-administration of Avandia with insulin, Edema, weight gain, hepatic effects, macular edema, fractures, hematologic effects, diabetes and blood glucose control, ovulation.